Annals of Oncology Research and Therapy

REVIEW ARTICLE
Year
: 2022  |  Volume : 2  |  Issue : 1  |  Page : 2--9

An overview of systematic evidence on oral microbial composition for orodigestive tract cancer risk


Steena Kuriakose1, RS Vinutha2, Krithiga Shridhar3 
1 Research Fellow, Centre for Chronic Disease Control, C-1/52, 2ND FL, Safdarjung Development Area, New Delhi, India
2 Senior Research Assistant, Public Health Foundation of India, Plot 47, Sector 44, Institutional Area, Gurgaon, Haryana, India
3 Senior Research Scientist & Associate Professor (adjunct), Epidemiologist, Public Health Foundation of India (PHFI), Plot 47, Sector 44, Institutional Area, Gurgaon, Haryana 122002; Research Scientist, Centre for Chronic Disease Control (CCDC), C-1/52, 2ND FL, Safdarjung Development Area, New Delhi, India

Correspondence Address:
Dr. Krithiga Shridhar
MDS, MSc, Centre for Chronic Conditions and Injuries, Public Health Foundation of India, No. 47, Sector 44, Gurgaon - 122 002, Haryana
India

We summarized published systematic reviews of studies evaluating oral microbial composition for orodigestive cancer risk. A PubMed literature search was conducted for the most recent time period between January 1, 2019 and April 25, 2022, for systematic reviews in English language using keywords and MeSH terms in combination. Seven systematic reviews included all published observational studies until June 2021 with 8–34 individual studies evaluated in each of those reviews. The individual studies were primarily hospital-based case–control studies with only six population-based evaluations (five prospective; one case control). The oral cavity, oro-and hypopharynx, esophagus, stomach, colorectum, liver, and pancreas were the cancer sites investigated. Saliva, oral rinse, subgingival and dental plaque, surface tissue swabs, biopsy tissue specimens, and tongue-coating samples were analyzed for oral microbial composition using next-generation sequencing techniques primarily 16S rRNA sequencing. The total sample size in different reviews ranged between 578 and 2769 cases and 261 and 3519 controls with small individual studies (3–250 cases and 2–465 controls). To date, there were four hospital-based case–control studies from India. The overall findings were restricted to bacterial communities. Compared to controls, the alpha-and beta-diversity for these cancer sites either showed no difference or inconsistent patterns. A few noteworthy differential abundances at the genus level for selected cancer sites included oral cavity – increased Fusobacterium, Parvimonas, and Peptostreptococcus and decreased Streptococcus, colorectum – increased Fusobacterium, Gemella, Peptostreptococcus, Prevotella, and Lautropia, pancreas – increased Porphyromonas and Alloprevotella, and esophagus – increased Tannerella. For clinical and public health translation, the identified leads might require validations in prospective population-based studies with rigorous methods, species-level characterizations, and functional analysis to prove causal associations.


How to cite this article:
Kuriakose S, Vinutha R S, Shridhar K. An overview of systematic evidence on oral microbial composition for orodigestive tract cancer risk.Ann Oncol Res Ther 2022;2:2-9


How to cite this URL:
Kuriakose S, Vinutha R S, Shridhar K. An overview of systematic evidence on oral microbial composition for orodigestive tract cancer risk. Ann Oncol Res Ther [serial online] 2022 [cited 2022 Dec 2 ];2:2-9
Available from: http://www.aort.com/article.asp?issn=WKMP-0208;year=2022;volume=2;issue=1;spage=2;epage=9;aulast=Kuriakose;type=0